New data presented at Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Colorado Spring highlights the cutting-edge, AI-enabled technology that has been developed for the Brainomix 360 Stroke platform
The project will evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US
New guidance from NICE, the globally respected health assessor, endorses the use of Brainomix 360 Stroke, acknowledging the impact that the AI-enabled software has demonstrated on stroke care, expanding patient access to life-changing treatments. Brainomix was one of only two companies granted this highly coveted endorsement.
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics
The results generated by Brainomix's core lab analysis with its AI software reinforced glenzocimab's mode of action in stroke patients
Sites with e-Stroke are delivering higher thrombectomy rates for stroke patients in a faster time, according to a recent report from the Oxford Academic Health Science Network
We've relocated to the landmark Seacourt Tower in Botley
The Oxford-based company is the first AI imaging company to join the organization
Our stroke AI solutions are now poised to take its transformative technology to US stroke centers
The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients
Strategic partnership increases access to advanced AI-assisted stroke care
Brainomix to distribute Pixyl.Neuro.MS Software as a Service (SaaS) solution exclusively in the UK and Ireland, the Nordics and key Eastern Europe markets
Benefits of combining Visionable’s virtual platform with Brainomix’s e-Stroke imaging already demonstrated at Ipswich Hospital
Study to evaluate e-ACT for automated assessment of disease progression and treatment response for lung cancer
The partnership will focus on quantitative analysis of imaging data by Brainomix's e-ILD software within the Phase 2 Study of BBT-877 in IPF
Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.
New CFO and CRO appointed with overall resources more than doubling following last December’s £16M financing round
The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical trials
The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials
The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets
Brainomix were awarded the first national tender in Europe to deploy its AI stroke software as part of the Polish Ministry of Health initiative to improve stroke care
The partnership will enable both companies to work towards improving care across stroke networks
Joins renowned global organization connecting academia, industry and philanthropy in the fight against lung disease
The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims
Partnership will enable both companies to help improve stroke care across the region
Funding will enable Brainomix to further commercialize its proprietary software
Brainomix Limited, a developer of automated medical imaging software for neurological
Breakthrough technology automates analysis of CT brain scans to support doctors in